baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

AES Corp/ US00130H1059 /

2024-04-25 10:10:00 PM	Chg. -0.24	Volume	Bid3:04:43 PM	Ask3:04:43 PM	Market Capitalization	Dividend Y.	P/E Ratio
17.13USD	-1.38%	4.47 mill. Turnover: 65.69 mill.	17.02Bid Size: 600	17.27Ask Size: 100	12.17 bill.USD	3.91%	46.30

GlobeNewswire 2:00 PM MAX Power Makes High-Grade Lithium Discovery at Arizona’s Willcox Playa

GlobeNewswire 04-18 Barinthus Bio Announces Topline Data from Phase 1b/2 APOLLO Trial of VTP-200 in Persistent High-Risk...

GlobeNewswire 04-16 AskBio presents 18-month Phase Ib trial results of AB-1005 gene therapy for patients with Parkinson’...

GlobeNewswire 04-16 Q1 Surge: Banzai Welcomes Over 580 New Customers in Q1

GlobeNewswire 04-16 Incannex Healthcare Inc. Quarterly Update, Q1 2024

GlobeNewswire 04-15 Pulmocide Announces Successful Results from the OPERA-S Study: a Phase 2 Safety Study with Inhaled O...

GlobeNewswire 04-10 Aprea Therapeutics Announces Presentations on its Next Generation WEE1 Inhibitor, APR-1051, and A No...

GlobeNewswire 04-10 Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and Hi...

GlobeNewswire 04-10 Rugby Resources Commences Exploration at the Mantau Copper-Gold Project, Chile

GlobeNewswire 04-09 Edward Hall Nominated to Join the Board of Directors of TPI Composites, Inc.

GlobeNewswire 04-09 Spectra Logic Introduces LumOS Library Management Software with Two New Libraries

GlobeNewswire 04-08 Positive Results for Patients with Non-obstructive Hypertrophic Cardiomyopathy Treated with Ninerafa...

GlobeNewswire 04-08 Inozyme Pharma Announces Positive Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults wi...

GlobeNewswire 04-06 Ocular Therapeutix™ Announces Positive Phase 2 PAXTRAVA™ Glaucoma Data at the American Society of Ca...

GlobeNewswire 04-03 Brixton Metals Reports Best Copper-Gold-Silver Results to Date from the Hog Heaven Project

GlobeNewswire 04-02 Onconova Therapeutics, Inc. and Trawsfynydd Therapeutics, Inc. Announce Business Combination to Form...

GlobeNewswire 04-01 Gritstone bio Announces Positive Preliminary Progression-free Survival and Long-term Circulating Tum...

GlobeNewswire 04-01 Disc Reports Topline Results from Phase 2 AURORA Study of Bitopertin in Patients with Erythropoietic...

GlobeNewswire 03-28 Milestone Pharmaceuticals Announces Resubmission of New Drug Application for Etripamil for Treatment...

GlobeNewswire 03-27 atai Life Sciences Announces Positive Initial Results from Beckley Psytech’s Phase 2a Open Label Stu...

GlobeNewswire 03-26 Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2

GlobeNewswire 03-22 Titan Reports 16% Increase in Production While Lowering Costs

GlobeNewswire 03-21 Banzai Signs 200 Customers in February

GlobeNewswire 03-21 Bionomics Reports Results of the Full Dataset Analysis from ATTUNE Phase 2b Trial of BNC210 in Patie...

GlobeNewswire 03-20 Orchard Therapeutics Outlines U.S. Launch Plans for Lenmeldy™ (atidarsagene autotemcel), the Only Ap...

AES Corp/ US00130H1059 /

If you wish to receive reply to your feedback, please provide your email address.